Erythropoietin protects lipopolysaccharide-induced renal mesangial cells from autophagy

Lingyun Bi1, Ruanling Hou2, Dasheng Yang1

  • 1Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.

Insights

Erythropoietin (EPO) was found to inhibit lipopolysaccharide (LPS)-induced autophagy in rat glomerular mesangial cells (GMCs). This study explored EPO

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Autophagy plays a critical role in cellular homeostasis.
  • Lipopolysaccharide (LPS) can induce autophagic dysfunction.
  • Glomerular mesangial cells (GMCs) are key players in kidney function.

Purpose of the Study:

  • To investigate the effects of erythropoietin (EPO) on LPS-induced autophagy impairment.
  • To examine EPO's impact on autophagy markers in rat GMCs.

Main Methods:

  • Primary rat GMCs were cultured under various conditions: normal glucose, high-glucose, LPS, and LPS + EPO.
  • Western blot analysis was used to assess the expression of autophagy markers LC3 and p62/SQSTM1 at 24 and 72 hours.

Main Results:

  • High-glucose and LPS exposure for 72 hours altered autophagy marker expression (downregulated LC3, upregulated p62/SQSTM1).
  • Erythropoietin (EPO) treatment reversed these LPS-induced changes in autophagy markers.
  • No significant differences were observed at 24 hours.

Conclusions:

  • Erythropoietin (EPO) effectively inhibits lipopolysaccharide (LPS)-induced autophagy in rat glomerular mesangial cells (GMCs).
  • EPO may have a protective role against LPS-induced cellular stress in GMCs.